To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Paul Capital injects £17.5m into ML Laboratories
US private equity firm Paul Capital is funding US clinical trials of Adept, a product manufactured by UK-based pharmaceutical business ML Laboratories
